Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized low-molecular-weight heparin plus salbutamol versus salbutamol alone for acute asthma attack
IRCT2015092215446N4Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- May 2015
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of low molecular weight heparin calcium and salbutamol in asthma (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started May 2015; status: completed.
02
Drugs
low molecular weight heparin calciumsalbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on IRCT2015092215446N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015092215446N4.